web analytics

Description

Extraocular tumors are increased in patients with hereditary retinoblastoma and their family members. The risk of secondary tumor is significant in children treated with radiation therapy who survive for many years. A patient who survives retinoblastoma and family members should be monitored for extra-ocular tumors, which may be benign or malignant.


 

Possible scenarios:

(1) extraocular tumor as sole manifestation (need a careful ocular exam to exclude spontaneously regressed retinoblastoma)

(2) extraocular tumor in a patient with hereditary retinoblastoma as a manifestation of increased cancer risk

(3) extraocular tumor in a patient with retinoblastoma following radiation and/or chemotherapy

 

Extra-ocular tumors that may develop associated with an RB1 mutation:

(1) pinealoma (if patient has a retinoblastoma, concurrent pinealoma referred to as a “trilateral” retinoblastoma because of retina-like tissue in the pineal gland)

(2) osteosarcoma

(3) other types of sarcoma

(4) multiple lipomas

(5) malignant melanoma

(6) brain tumors (meningioma, benign gliomas, malignant gliomas)

(7) leukemia

(8) cancers of breast, kidney, esophagus, colon, urinary bladder, thyroid gland, ovary, endometrium, lung, other

 

Risk factors for an extraocular tumor:

(1) radiation therapy

(2) aggressive chemotherapy

(3) bilateral disease

(4) long-term survival

 


To read more or access our algorithms and calculators, please log in or register.